Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

158.86
+2.621.68%
Post-market: 160.001.14+0.72%19:41 EDT
Volume:1.18M
Turnover:187.89M
Market Cap:303.10B
PE:24.02
High:159.72
Open:156.17
Low:156.10
Close:156.24
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.73
T/O Rate:0.06%
Dividend:4.67
Dividend Rate:2.94%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:7.30
PE(LYR):22.22

Loading ...

Novartis announces prequalification for Coartem Baby by WHO

TIPRANKS
·
Apr 24

Novartis Antimalarial Treatment Set for Widespread Adoption in Malaria-Endemic Regions

MT Newswires Live
·
Apr 24

Evotec Names Claire Hinshelwood Chief Financial Officer

MT Newswires Live
·
Apr 24

Novartis AG expected to post earnings of $2.00 a share - Earnings Preview

Reuters
·
Apr 24

This Pharma Stock Is Up 460% Over the Past Year. What Could Be Key to Future Gains. -- Barrons.com

Dow Jones
·
Apr 21

Earnings Preview: Novartis AG Q1 revenue expected to increase by 2.29%, institutional views are broadly constructive

Earnings Agent
·
Apr 21

Dow Jones Top Company Headlines at 9 PM ET: Elon Musk's xAI Sued by NAACP Over Memphis Data Center | China-Backed ...

Dow Jones
·
Apr 15

Anthropic adds Novartis CEO Vas Narasimhan to its board

Reuters
·
Apr 14

Anthropic Appoints Novartis CEO Vas Narasimhan to Its Board

Deep News
·
Apr 14

Novartis Investors to Focus on Pipeline Update Amid Weak Results -- Market Talk

Dow Jones
·
Apr 10

Novartis to Expand Community Health Programs to More Countries

MT Newswires Live
·
Apr 09

AZN, NVO, NVS: What Does Trump’s New 100% Tariff Mean for Pharma Giants?

TIPRANKS
·
Apr 03

Trump Will Impose 100% Tariff on Some Patented Drugs

Tiger Newspress
·
Apr 03

Novartis Likely to Confirm Guidance -- Market Talk

Dow Jones
·
Apr 02

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Fresh Economic Data

MT Newswires Live
·
Mar 30

Novartis Says Drug Improves Kidney Function in Patients With Berger's Disease

MT Newswires Live
·
Mar 30

Global Equities Roundup: Market Talk

Dow Jones
·
Mar 30

Novartis to Take Earnings Hit From Generic Competition -- Market Talk

Dow Jones
·
Mar 30

Novartis announces two-year results from Phase III APPLAUSE-IgAN study

TIPRANKS
·
Mar 30

Novartis to buy biotech company Excellergy for up to $2B

TIPRANKS
·
Mar 27